Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective.
van Asten F, Michels CTJ, Hoyng CB, van der Wilt GJ, Klevering BJ, Rovers MM, Grutters JPC. van Asten F, et al. Among authors: van der wilt gj. PLoS One. 2018 May 17;13(5):e0197670. doi: 10.1371/journal.pone.0197670. eCollection 2018. PLoS One. 2018. PMID: 29772018 Free PMC article.
Zinc supplementation inhibits complement activation in age-related macular degeneration.
Smailhodzic D, van Asten F, Blom AM, Mohlin FC, den Hollander AI, van de Ven JP, van Huet RA, Groenewoud JM, Tian Y, Berendschot TT, Lechanteur YT, Fauser S, de Bruijn C, Daha MR, van der Wilt GJ, Hoyng CB, Klevering BJ. Smailhodzic D, et al. Among authors: van asten f, van de ven jp, van der wilt gj, van huet ra. PLoS One. 2014 Nov 13;9(11):e112682. doi: 10.1371/journal.pone.0112682. eCollection 2014. PLoS One. 2014. PMID: 25393287 Free PMC article. Clinical Trial.
Progression of Late-Onset Stargardt Disease.
Lambertus S, Lindner M, Bax NM, Mauschitz MM, Nadal J, Schmid M, Schmitz-Valckenberg S, den Hollander AI, Weber BH, Holz FG, van der Wilt GJ, Fleckenstein M, Hoyng CB; Foveal sparing Atrophy Study Team (FAST). Lambertus S, et al. Among authors: van der wilt gj. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5186-5191. doi: 10.1167/iovs.16-19833. Invest Ophthalmol Vis Sci. 2016. PMID: 27699414 Clinical Trial.
Asymmetric Inter-Eye Progression in Stargardt Disease.
Lambertus S, Bax NM, Groenewoud JM, Cremers FP, van der Wilt GJ, Klevering BJ, Theelen T, Hoyng CB. Lambertus S, et al. Among authors: van der wilt gj. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6824-6830. doi: 10.1167/iovs.16-20963. Invest Ophthalmol Vis Sci. 2016. PMID: 28002570
Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease.
Lambertus S, Bax NM, Fakin A, Groenewoud JM, Klevering BJ, Moore AT, Michaelides M, Webster AR, van der Wilt GJ, Hoyng CB. Lambertus S, et al. Among authors: van der wilt gj. PLoS One. 2017 Mar 29;12(3):e0174020. doi: 10.1371/journal.pone.0174020. eCollection 2017. PLoS One. 2017. PMID: 28355279 Free PMC article.
215 results